Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
431.62
+1.52 (0.35%)
May 22, 2026, 3:44 PM EDT - Market open
Medpace Holdings Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Medpace Holdings stock has a consensus rating of "Hold" and an average price target of $442.83. The average 1-year stock price forecast is 2.60% higher than the current stock price, while the lowest is $329 (-23.78%) and the highest is $495 (+14.68%).
Price Target: $442.83 (+2.60%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medpace Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Hold | 8 | 8 | 8 | 9 | 7 | 7 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 1 | 1 | 1 | 1 |
| Total | 12 | 12 | 12 | 13 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $500 → $450 | Hold | Maintains | $500 → $450 | +4.26% | Apr 24, 2026 |
| BMO Capital | BMO Capital | Hold Maintains $460 → $400 | Hold | Maintains | $460 → $400 | -7.33% | Apr 24, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $522 → $484 | Buy | Maintains | $522 → $484 | +12.14% | Apr 24, 2026 |
| Baird | Baird | Buy Maintains $565 → $477 | Buy | Maintains | $565 → $477 | +10.51% | Apr 24, 2026 |
| Barclays | Barclays | Sell → Hold Upgrades $500 | Sell → Hold | Upgrades | $500 | +15.84% | Mar 6, 2026 |
Financial Forecast
Revenue This Year
2.83B
from 2.53B
Increased by 11.93%
Revenue Next Year
2.97B
from 2.83B
Increased by 5.01%
EPS This Year
17.32
from 15.28
Increased by 13.33%
EPS Next Year
18.75
from 17.32
Increased by 8.28%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.0B | 3.4B | ||||||
| Avg | 2.8B | 3.0B | ||||||
| Low | 2.6B | 2.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 18.1% | 20.3% | ||||||
| Avg | 11.9% | 5.0% | ||||||
| Low | 3.9% | -12.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 18.23 | 20.22 | ||||||
| Avg | 17.32 | 18.75 | ||||||
| Low | 16.37 | 17.05 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 19.3% | 16.8% | ||||||
| Avg | 13.3% | 8.3% | ||||||
| Low | 7.1% | -1.5% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.